8th ACE Drug Discovery Summit 

14th – 15th April 2027

London UK

About Us

The 8th Ace Drug Discovery Summit London, UK 2027 is a premier scientific forum uniting global researchers, biotech leaders, and pharma innovators to explore the latest advancements transforming drug discovery. This two-day summit features cutting-edge sessions on AI-driven drug design, quantum computing in simulation, targeted protein degradation, RNA therapeutics, and sustainable medicinal chemistry. Key discussions will highlight CAR-T cell therapies, immunotherapy combinations, bioinformatics, and nanomedicine, reflecting the evolving landscape of pharmaceutical R&D. Attendees will gain actionable insights into emerging technologies, fragment-based drug design, and AI-powered screening, with a strong focus on unmet medical needs and ethical considerations. With interactive panel discussions, expert-led presentations, and exclusive business meetings, the summit fosters meaningful collaboration and knowledge exchange across the drug development spectrum. Join us to stay at the forefront of innovation and reshape the future of drug discovery and therapeutic development.

Why Attend

Attendees
0 +
Speakers
0 +
Companies
0 +
Networking Hours
0 +

Solutions at ADDS

🔷Antibody Engineering
🔷Biochemistry
🔷Bio-informatics
🔷ADMUPI (Toxicology)
🔷Biomarker Validation
🔷Combinatorial Chemistry
🔷Covering Biological studies
🔷Data Management
     Technology

🔷Digital Imaging Technology
🔷DNA & RNA Analysis
🔷DNA Sequencing Services
🔷Drug Discovery Technology
     Platforms
🔷Preclinical
🔷Principal Scientists
🔷Regulatory Affairs

🔷Research & Development
🔷Transgenesis Services
🔷Genomics
🔷High Throughput Screening
🔷Licensing
🔷lmaging/biomarker
🔷Imaging Tools

Who Will Attend

8th Ace Drug Discovery Summit London, UK 2027 is a premier scientific forum uniting global researchers, biotech leaders, and pharma innovators to explore the latest advancements transforming drug discovery

🔷CEO
🔷CSO
🔷Director Discovery Alliances
🔷Head of DMPK
🔷Head of Drug Design

🔷Head of Molecula Toxicology
🔷VP Target Discovery & Assessment
🔷Head of R&D Licensing
🔷Principal Scientist

🔷Director of Discovery Strategy Portfolio
🔷Director of Screening & Compound Profiling
🔷Executive Director Chemistry
🔷Head Pharmacology & Toxicology
🔷Drug Discovery R&D Executives

Speakers Panel 2026

Norman Miller

Co-Founder And CSO
| Kutanios Ltd

 

Asif Ahmed 

Founder And CEO |
MIRZYME THERAPEUTICS LIMITED

John Maher

CSO |
Leucid Bio

Gergely Toth

CEO & CSO |
Cantabio Pharmaceuticals

Mark Eccleston

CEO | ValiRx

ARIJIT PATRA

Senior Principal Scientist |
UCB

Mikko Turunen

Founder, CSO |
RNatives Inc.

Sanjib Bhakta

Professor of Molecular Microbiology And Biochemistry |
UCL And Birkbeck, University of London

Kraiem Merabet Manel

CDO | SKYMAB BIOTHERAPEUTICS

Adele Rowley

Chief Scientific Officer | Mironid

Patrizia Anna d’Alessio

CEO |
 AISA Therapeutics

Maria Carmen Visus Miguel

Senior Director R&D Operations | AOP HEALTH

Philip M Arlen

CEO | Precision Biologics

Shayoni Dutta

Data Science Manager | GSK

Kayleigh Thirlwell

Senior Director | Resolution Therapeutics

Alan PALMER

CEO | Elixa Mediscience

Monica Reis

Group Leader | Resolution Therapeutics

Nahuel Villegas

CSO | Vivan Therapeutics

Duygu Dikicioglu

Associate Professor in Digital Bioprocess Engineering | University of College London

Juan Carlos Mobarec

Head Computational Structural Biology | Astrazeneca

Sara Hegy

Founder Coach and Scientist | GenX Leadership Academy

Stephen Harrison

Founder | Chiton Biosciences

Kathryn Armour

Principal Scientist | LifeArc

SONIA MACIA ESCALANTE

Chief Medical Officer | OneChain Immunotherapeutics

John Spencer

Professor/Director of MedChem, SDDC | Sussex Drug Discovery Centre

Darcie Mulhearn

Target Discovery Team Leader | PhoreMost

Vasiliki E Kalodimou

Director Flow Cytometry-Research and Regenerative Medicine | EUC Frankfurt Branch

Morten Grunnet

Vice President, Head of Neuroscience | Lundbeck

Alejandra Tomas

Professor of Cell Biology |
Imperial College London

Alexander Seifalian

Director/Professor of Nanotechnology & Regenerative Medicine |
Liberum Health

Jonathan Mason

Senior Research Advisor, Computational Chemistry |
Centessa Pharmaceuticals

Jose L Lanciego

Senior Scientist |
Center for Applied Medical Research (CIMA) University of Navarra

Speakers Panal 2026

Michael Watts

Associate Chief Clinical Informatics Officer | University Hospitals Derby And Burton NHS Trust

Vlad Anisimov

Data Science Director |
Amgen

Amer Alghabban

RDQ Inspection Management | Bristol Myers Squibb (BMS)

Lara Bloom

CEO & President | The Ehlers-Danlos Society

Chloe Citalois

Clinical Research Associate (Site Manager) | Independent

Sam Whatling

Director Clinical QA |
Autolus

Aldir Medeiros Filho

Clinical Data Scientist |Independent

Sridevi Nagarajan

Strategy Consultant | Ayusarogya

Puja Myles

Director, Clinical Practice Research Datalink | Medicines and Healthcare products Regulatory Agency

Carolina Narvaez

Patient Safety & Pharmacovigilance Global Expert, Former Head of Patient Safety, Novartis | N.A.

Nika Zigante

Clinical Supply Specialist | MEIRAGTX LIMITED

Sarah Deeley

Director, Country and Site Operations | Biogen

Arunesh Sil

UK &IE Medical Head for Transplant | Sanofi

Lavita Menezes

Director, Clinical Operations | Silence Therapeutics

Wiktor Majewski

Central Statistical Monitor | GSK

Barry Daly

Director | ImpactfulRx
 

 

Sara Hegy

Founder Coach and Scientist | GenX Leadership Academy

Daizy Moumi

Associate Director of Clinical Operations | Complement Therapeutics

Svetlana Karova

Manager, Clinical Risk and Analytics | Alnylam Pharmaceuticals

HEND ABDELHAKIM

Assisant Professor , Pharmaceutical Scientist | UCL , Gustoceutics

Meelis Lootus

CEO | Tehistark OÜ

Lorelle Brownlee

Co-Founder | Composed Health

Martina Barcaroli

Global Senior Study Manager | Angelini Pharma

Madjlessi Gabrielle

International Clinical Operation Lead | Servier

Mark Sweeney

PhD Candidate | ServierImperial College London 

Sanjeev Srivastav

Signal Management Lead | BioNTech

Ilves Sanna

Head of Pharmacy Clinical Trials & Aseptic Services | The Royal Marsden Hospital

Maryna Todoriuk, MPharm, BBA

Founder | CL Group

Our Sponsors

10x_GENOMICS_LOGO

Attendee Breakdown

Attendee Demographics

Conference Themes

14th April

AI-Enabled Discovery in Small Molecules
Computational Target Discovery and Protein Design
Deep Learning for ADCs and Next-Generation Design
 PK/PD Modelling in Early Drug Discovery Programs
Drug discovery and development for rare genetic disorders
AI in Drug Discovery: From Concept to Implementation
Future Perspectives for AI in the Drug Discovery

15th April

   Next-Generation Gene Therapy for Neurological 
Genomic Targets, Biomarkers and Targeted Therapies
MRNA Therapeutics: From Discovery to Clinical Translation
Predictive Toxicology for Safer Early Drug Development
 AI-Driven Target Discovery and Novel Therapeutic Strategies
Turning Scientific Discoveries into Effective Therapies
Biomarker Validation for Drug Development

Our Partners

Media Partners

Marriott International begins as an A&W Root Beer franchise in Washington, D.C., in May 1927, with the same core values that guide the company today. Founders J. Willard and Alice Sheets Marriott get their business started by quenching people’s thirst during the hot, muggy summers in Washington, D.C., before serving food and becoming The Hot Shoppes, and entering other lines of business. Heralding in a new era in 2016, Marriott International acquires Starwood Hotels & Resorts Worldwide creating the world’s largest hotel company. There is a celebration in New York City’s Time Square.

Join industry leaders at the 8th ACE Drug Discovery Summit .